Complex regional pain syndrome

Complex regional pain syndrome
Timsong311 · CC BY-SA 3.0 · source
Name	Complex regional pain syndrome
Field	Pain medicine, Neurology, Orthopedics
Symptoms	Severe regional pain, allodynia, vasomotor changes, motor dysfunction
Complications	Chronic disability, mood disorders
Onset	Often after injury or surgery
Causes	Multifactorial: nerve injury, inflammation, autonomic dysfunction
Diagnosis	Clinical criteria, imaging, autonomic testing
Treatment	Multimodal: medications, physical therapy, interventions
Frequency	Rare to uncommon

Complex regional pain syndrome Complex regional pain syndrome (CRPS) is a chronic pain condition characterized by persistent, disproportionate regional pain usually affecting a limb after injury or surgery. It often involves sensory, autonomic, motor and trophic changes and can lead to significant functional impairment and psychological distress.

Overview

CRPS is classified into subtype schemes that guide clinical practice and research similarly to how World Health Organization classifications guide global health, or how American Medical Association coding guides billing, and it appears in specialty guidelines from organizations like International Association for the Study of Pain, National Institute for Health and Care Excellence, and national societies such as American Academy of Neurology and European Federation of Neurological Societies. The condition has historically been described under terms used in reports from institutions like Mayo Clinic, Johns Hopkins Hospital, and case series from centers including Massachusetts General Hospital, Cleveland Clinic, and research hubs such as Stanford University and University College London. Management pathways draw on multidisciplinary models similar to programs at Hospital for Special Surgery, Rothman Orthopaedic Institute, and rehabilitation units at Spaulding Rehabilitation Hospital.

Signs and symptoms

Patients present with an array of regional features noted in clinical summaries from centers like Mount Sinai Health System, Barnes-Jewish Hospital, and Toronto General Hospital, with severe spontaneous pain, hyperalgesia, and allodynia alongside vasomotor signs of altered skin temperature and color that resemble autonomic findings reported by teams at Cedars-Sinai Medical Center, Brigham and Women's Hospital, and UCLA Health. Motor symptoms include weakness, tremor, and decreased range of motion akin to dysfunction cataloged in case series from Royal National Hospital for Rheumatic Diseases, Sheffield Teaching Hospitals, and Guy's and St Thomas' NHS Foundation Trust; trophic changes affecting nails, hair and skin have been highlighted in reviews from Karolinska Institutet, University of Sydney, and University of Toronto. Comorbid psychiatric and cognitive sequelae—such as depression, anxiety, and sleep disturbance—are noted in longitudinal cohorts from University of Oxford, King's College London, and University of Cambridge.

Causes and pathophysiology

Etiology is multifactorial, drawing on mechanisms studied at research centers including National Institutes of Health, Max Planck Society, and Instituto de Salud Carlos III, with proposed drivers such as peripheral nerve injury described in electrophysiology studies from Mayo Clinic and inflammatory cascades characterized by groups at Harvard Medical School and Yale School of Medicine. Central sensitization and maladaptive neuroplasticity implicate central nervous system regions explored by teams at Karolinska Institutet, Cold Spring Harbor Laboratory, and University of California, San Francisco, while autonomic dysregulation involving sympathetic pathways has been investigated by investigators at Johns Hopkins University, Duke University, and University of Michigan. Immune-mediated mechanisms and microglial activation have been reported in experimental models from Columbia University, University of Zurich, and ETH Zurich, and genetic predisposition signals have been examined in cohorts assembled by consortia such as UK Biobank, All of Us Research Program, and Framingham Heart Study for insights into susceptibility.

Diagnosis

Diagnosis is clinical using criteria developed and refined by panels including members from International Association for the Study of Pain, World Health Organization, and national specialty societies like Royal College of Physicians and American Pain Society; tools such as the Budapest criteria are used in practice at clinics including Toronto Rehabilitation Institute, Rehabilitation Institute of Chicago, and R Adams Cowley Shock Trauma Center. Ancillary testing—thermography, three-phase bone scintigraphy, magnetic resonance imaging—has been applied in studies from Mayo Clinic, Johns Hopkins Hospital, and University College London Hospital to support diagnosis or exclude mimics such as neuropathic pain syndromes characterized in literature from Boston Children's Hospital, Great Ormond Street Hospital, and SickKids Hospital. Electrophysiologic testing and quantitative sensory testing are utilized in diagnostic pathways at centers like Massachusetts General Hospital and Stanford Health Care.

Treatment and management

Management is multidisciplinary, following models used at Spaulding Rehabilitation Hospital, Mayo Clinic, and Cleveland Clinic, combining pharmacotherapy (neuropathic agents, opioids in select cases), physical and occupational therapy, psychological interventions such as cognitive behavioral therapy offered at Sheffield Teaching Hospitals and UCSF Medical Center, and interventional procedures (sympathetic nerve blocks, spinal cord stimulation) available at tertiary centers like Johns Hopkins Hospital, Mount Sinai Health System, and University of Pittsburgh Medical Center. Rehabilitation emphasizes graded use and desensitization techniques implemented in programs at University of Washington, McGill University Health Centre, and Rehab UK, while novel treatments—including immunomodulation and neuromodulation—are being trialed in research networks such as National Institutes of Health-funded consortia, European Research Council projects, and investigator-initiated studies at Massachusetts General Hospital and Vanderbilt University Medical Center.

Prognosis and outcomes

Outcomes vary: some individuals recover with early, aggressive multidisciplinary care as documented in cohorts from Johns Hopkins Hospital and Mayo Clinic, while others develop persistent disability with chronic pain, reduced quality of life, and secondary mood disorders reported in long-term follow-up studies from University College London and Karolinska Institutet. Functional prognosis correlates with factors identified in registry analyses from Danish National Patient Registry, Swedish National Patient Register, and Norwegian Patient Registry, and health-economic impact assessments have been modelled by groups at Harvard School of Public Health, London School of Economics, and University of Toronto.

Epidemiology and risk factors

CRPS incidence and prevalence estimates derive from population studies from sources like Danish National Patient Registry, Finnish Institute for Health and Welfare, and Swedish National Board of Health and Welfare, with reported rates varying across cohorts studied at Johns Hopkins Bloomberg School of Public Health, Imperial College London, and Robert Koch Institute. Risk factors include antecedent trauma or surgery described in registries at National Joint Registry for England, Wales and Northern Ireland, peripheral nerve injury cases compiled by American Association of Neurological Surgeons, and patient-level risk correlates reported in multicenter studies coordinated by European Pain Federation, American Pain Society, and International Association for the Study of Pain.

Category:Chronic pain conditions